First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE

BACKGROUND: ENCORE, an observational, prospective, open‐label study, investigated real‐world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) in first‐line (1L) recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). AIMS: This multinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Tourneau, Christophe, Ghiani, Massimo, Cau, Maria Chiara, Depenni, Roberta, Ronzino, Graziana, Bonomo, Pierluigi, Montesarchio, Vincenzo, Leo, Luigi, Schulten, Jeltje, Salmio, Satu, Messinger, Diethelm, Sbrana, Andrea, Borcoman, Edith, Ghi, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172179/
https://www.ncbi.nlm.nih.gov/pubmed/37069784
http://dx.doi.org/10.1002/cnr2.1804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172179/
https://www.ncbi.nlm.nih.gov/pubmed/37069784
http://dx.doi.org/10.1002/cnr2.1804

Ejemplares similares